Application of multiple response optimization technique to extended release formulations design

被引:125
作者
Hamed, E [1 ]
Sakr, A [1 ]
机构
[1] Univ Cincinnati, Coll Med, Ind Pharm Program, Cincinnati, OH 45267 USA
关键词
response surface methodology; multiple response optimization; bumetanide; extended release; coating;
D O I
10.1016/S0168-3659(01)00356-X
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The purpose of the present study wits to apply response surface methodology and multiple response optimization utilizing superimposed contour diagrams to design extended release formulations with a preplanned release profile. Bumetanide solution was layered on sugar pellets followed by coating with various coating formulations according to a central composite statistical design using a Glatt GPCG 1 Wurster Fluid Bed. The coated pellets were tested for their release profiles and the percent of drug released after 1. 4 and 8 h were used to describe and optimize the release process. Statistical models describing the percent bumetanide released after 1, 3 and 8 h were developed and the corresponding contour diagrams were superimposed to predict the coating formulation parameters expected to produce target release profile. The pellets coated with the designed coating formulation were tested for their release profiles in comparison to the target profile. According to the model-independent approach using similarity factor (F-2), the dissolution profile of the designed formulation and the expected target profile were found to be similar. It was concluded that response surface methodology and multiple response optimization could be successfully used to design and optimize extended release formulations with desired preplanned release profile. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:329 / 338
页数:10
相关论文
共 22 条
[1]   DISCREPANCY BETWEEN BIOAVAILABILITY AS ESTIMATED FROM URINARY RECOVERY OF FRUSEMIDE AND TOTAL DIURETIC EFFECT [J].
ALVAN, G ;
PAINTAUD, G ;
ECKERNAS, SA ;
GRAHNEN, A .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 34 (01) :47-52
[2]   Optimization of propranolol hydrochloride sustained release pellets using a factorial design [J].
Bodea, A ;
Leucuta, SE .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1997, 154 (01) :49-57
[3]   DRY AND WET STRENGTHS OF POLYMERIC FILMS PREPARED FROM AN AQUEOUS COLLOIDAL POLYMER DISPERSION, EUDRAGIT RS30D [J].
BODMEIER, R ;
PAERATAKUL, O .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1993, 96 (1-3) :129-138
[4]   INFLUENCE OF DRUG FORMULATION ON DRUG CONCENTRATION-EFFECT RELATIONSHIPS [J].
CASTANEDAHERNANDEZ, G ;
CAILLE, G ;
DUSOUICH, P .
CLINICAL PHARMACOKINETICS, 1994, 26 (02) :135-143
[5]   The application of an artificial neural network and pharmacokinetic simulations in the design of controlled-release dosage forms [J].
Chen, YX ;
McCall, TW ;
Baichwal, AR ;
Meyer, MC .
JOURNAL OF CONTROLLED RELEASE, 1999, 59 (01) :33-41
[6]   INFLUENCE OF PH AND PLASTICIZERS ON DRUG-RELEASE FROM ETHYLCELLULOSE PSEUDOLATEX COATED PELLETS [J].
HUTCHINGS, DE ;
SAKR, A .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1994, 83 (10) :1386-1390
[7]   PHARMACOKINETICS AND PHARMACODYNAMICS OF BUMETANIDE AFTER INTRAVENOUS AND ORAL-ADMINISTRATION TO RATS - ABSORPTION FROM VARIOUS GI SEGMENTS [J].
LEE, SH ;
LEE, MG ;
KIM, ND .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1994, 22 (01) :1-17
[8]  
LEHMANN KOR, 1997, AQUEOUS POLYM COATIN, P1
[9]  
Myers R. H., 1995, Response Surface Methodology: Process and Product Optimization Using Designed Experiments, DOI DOI 10.2307/1270613
[10]  
NOVITCH M, 2000, US PHARMACOPEIA, V24, P2000